NasdaqCM - Delayed Quote • USD
ImmuCell Corporation (ICCC)
At close: April 26 at 4:00 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2021) | Next Qtr. (Jun 2021) | Current Year (2021) | Next Year (2022) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -0.11 | -- | -- |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2021) | Next Qtr. (Jun 2021) | Current Year (2021) | Next Year (2022) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | -- |
Avg. Estimate | 5.4M | 3.26M | 16.65M | -- |
Low Estimate | 5.4M | 3.26M | 16.65M | -- |
High Estimate | 5.4M | 3.26M | 16.65M | -- |
Year Ago Sales | -- | 2.97M | 15.34M | 16.65M |
Sales Growth (year/est) | -- | 9.90% | 8.50% | -- |
Earnings History
CURRENCY IN USD | 6/30/2020 | 9/30/2020 | 12/31/2020 | |
---|---|---|---|---|
EPS Est. | -- | -0.1 | -0.08 | -0.04 |
EPS Actual | -- | -0.11 | -0.04 | 0.03 |
Difference | -- | -0.01 | 0.04 | 0.07 |
Surprise % | -- | -10.00% | 50.00% | 175.00% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2021) | Next Qtr. (Jun 2021) | Current Year (2021) | Next Year (2022) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0.05 | -0.08 | -0.11 | 0 |
30 Days Ago | 0.05 | -0.08 | -0.11 | 0 |
60 Days Ago | 0.05 | -0.08 | -0.11 | 0 |
90 Days Ago | 0.05 | -0.08 | -0.11 | 0 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2021) | Next Qtr. (Jun 2021) | Current Year (2021) | Next Year (2022) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | ICCC | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -- | -- | -- | 5.40% |
Next Qtr. | -- | -- | -- | 10.90% |
Current Year | -- | -- | -- | 4.50% |
Next Year | -- | -- | -- | 13.10% |
Next 5 Years (per annum) | -- | -- | -- | 10.94% |
Past 5 Years (per annum) | 53.90% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Initiated | Aegis Capital: Buy | 7/13/2020 |
Related Tickers
HSTC HST Global, Inc.
1.1100
+18.09%
IMMU.ST Mendus AB (publ)
0.4745
+0.96%
GBIM GlobeImmune, Inc.
0.0000
0.00%
GSTC GlobeStar Therapeutics Corporation
0.0009
0.00%
CSBR Champions Oncology, Inc.
5.02
-0.79%
GBLX GB Sciences, Inc.
0.0067
+6.85%
PRTC PureTech Health plc
28.50
+2.24%
FRTX Fresh Tracks Therapeutics, Inc.
0.9101
-1.14%
PRTG Portage Biotech Inc.
0.2402
-4.95%
LUMO Lumos Pharma, Inc.
2.7700
-1.07%